ARCHIVES

Harold Varmus Addresses the NCI Board of Scientific Advisors

This article is from The Cancer Letter archive.

Vol. 39 No. 10 | March 8, 2013

Download PDF Visit The Full Archive

Related Articles

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Funding Opportunities: AACR Accepting Submissions for Two Dream Team Grants

September 19, 2014

More Than 300 request RFP for New Community Oncology Program

May 25, 1979

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

In Brief: Kennedy Drops Health Care Institute Plan Senate Approves Dole Amendment On Patents

August 18, 1978